ID: ALA3125607

Max Phase: Preclinical

Molecular Formula: C13H13Br2NO

Molecular Weight: 359.06

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1CC(=O)C=C(Nc2ccc(Br)cc2Br)C1

Standard InChI:  InChI=1S/C13H13Br2NO/c1-8-4-10(7-11(17)5-8)16-13-3-2-9(14)6-12(13)15/h2-3,6-8,16H,4-5H2,1H3

Standard InChI Key:  PEGMDEQRYGGNHY-UHFFFAOYSA-N

Associated Targets(non-human)

Hippocampus 432 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.06Molecular Weight (Monoisotopic): 356.9364AlogP: 4.51#Rotatable Bonds: 2
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.92CX LogD: 3.92
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.84Np Likeness Score: -0.24

References

1. Edafiogho IO, Qaddoumi MG, Ananthalakshmi KV, Phillips OA, Kombian SB..  (2014)  Synthesis, neuronal activity and mechanisms of action of halogenated enaminones.,  76  [PMID:24565570] [10.1016/j.ejmech.2014.02.002]

Source